Abbott Labs Files 8-K on Officer Changes & Filings

Ticker: ABT · Form: 8-K · Filed: 2025-12-12T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, filing

Related Tickers: ABT

TL;DR

ABT filed an 8-K detailing officer changes and corporate updates.

AI Summary

Abbott Laboratories filed an 8-K on December 12, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also covers amendments to articles of incorporation or bylaws, changes in fiscal year, and financial statements and exhibits.

Why It Matters

This filing provides updates on key personnel changes and corporate governance at Abbott Laboratories, which could impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing is routine and reports on standard corporate events like director changes and officer appointments, with no immediate financial distress indicated.

Key Players & Entities

FAQ

What specific officer positions were affected by the changes reported in this 8-K?

The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers," but does not specify the exact positions in the provided text.

Were there any amendments to Abbott Laboratories' articles of incorporation or bylaws?

Yes, the filing explicitly lists "Amendments to Articles of Incorporation or Bylaws" as an item of information being reported.

Does this filing include any new financial statements?

Yes, the filing states that "Financial Statements and Exhibits" are being filed as part of this report.

What is the date of the earliest event reported in this 8-K?

The date of the earliest event reported is December 12, 2025.

What is the Standard Industrial Classification (SIC) code for Abbott Laboratories?

The SIC code for Abbott Laboratories is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001104659-25-120657.txt : 20251212 0001104659-25-120657.hdr.sgml : 20251212 20251212161048 ACCESSION NUMBER: 0001104659-25-120657 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20251212 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251212 DATE AS OF CHANGE: 20251212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 251568213 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 8-K 1 tm2533113d1_8k.htm FORM 8-K false --12-31 0000001800 Common Shares, Without Par Value ABT 0000001800 2025-12-12 2025-12-12 0000001800 us-gaap:CommonStockMember exch:XCHI 2025-12-12 2025-12-12 0000001800 us-gaap:CommonStockMember exch:XNYS 2025-12-12 2025-12-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value   ABT       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549       FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   December 12, 2025 Date of Report (Date of earliest event reported)   ABBOTT LABORATORIES (Exact name of registrant as specified in charter)       Illinois   1-2189   36-0698440 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)       100 Abbott Park Road Abbott Park , Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 224 ) 667-6100   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities Registered Pursuant to Section 12(b) of the Act:   Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Shares, Without Par Value ABT New York Stock Exchange NYSE Texas   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨ &#

View on Read The Filing